Evidence map›Paper›PMID 36365117›Full record

ArticlePharmaceutics2022

3D Printed Fractal-like Structures with High Percentage of Drug for Zero-Order Colonic Release.

Vicente Linares, Ángela Aguilar-de-Leyva, Marta Casas, Isidoro Caraballo

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vicente LinaresDepartment of Pharmacy and Pharmaceutical Technology, University of Seville, 41012 Seville, Spain.ORCID 0000-0002-3565-9839
Ángela Aguilar-de-LeyvaDepartment of Pharmacy and Pharmaceutical Technology, University of Seville, 41012 Seville, Spain.ORCID 0000-0002-2251-8906
Marta CasasDepartment of Pharmacy and Pharmaceutical Technology, University of Seville, 41012 Seville, Spain.ORCID 0000-0002-3439-9094
Isidoro CaraballoDepartment of Pharmacy and Pharmaceutical Technology, University of Seville, 41012 Seville, Spain.ORCID 0000-0003-1905-7755
Universidad de Sevilla · ES

Funding

Junta de Andalucía, Consejería de Economía, Conocimiento, Empresas y Universidad Project US-1380923Ministerio de ciencia e innovación. 10.13039/501100011033
6 · The paper itself

Abstract

Colonic drug delivery of drugs is an area of great interest due to the need to treat high prevalence colonic local diseases as well as systemic conditions that may benefit from the advantages associated to this route of drug administration. In the last decade, the use of 3D printing technologies has expanded, offering the possibility of preparing personalized medicines in small batches directly at the point of care. The aim of this work is to design a high drug loaded 3D printed system prepared by a combination of Fused Deposition Modelling (FDM) and Injection Volume Filling (IVF) techniques intended for zero-order colonic drug release. For this purpose, different batches of binary and ternary filaments based on the thermoplastic polyurethane Tecoflex EG-72D (TPU), theophylline anhydrous (AT) as model drug, and magnesium stearate as lubricant have been developed and characterized. Filaments with the highest drug load and the best rheological properties were selected for the manufacture of a printed fractal-like structure based on multiple toroids. This design was proposed to provide high surface area, leading to increased drug release and water uptake in the colonic region. This structure was 3D printed by FDM and then coated in a unique step by IVF technology using the enteric polymer DrugCoat S 12.5. This way, an additional coating process is avoided, reducing costs and production time. Studies of drug release confirmed the ability of the structures to provide a five-hour period of constant drug delivery in the colonic region.

Indexed as

3D printingcolonic drug deliveryextruded filamentsFDMfractal analysisIVFzero-order release

Identifiers

PMID36365117
PMCPMC9695807
OpenAlexW4307551986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.